Steven R. Ph.D. Gullans Insider Trading $TTPH TETRAPHASE PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Steven R. Ph.D. Gullans.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Steven R. Ph.D. Gullans. Steven R. Ph.D. Gullans is Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in Gemphire Therapeutics Inc. ($GEMP) and Interim President & CEO in Gemphire Therapeutics Inc. ($GEMP) and President & CEO in Gemphire Therapeutics Inc. ($GEMP).

Steven R. Ph.D. Gullans in TETRAPHASE PHARMACEUTICALS INC

Trading Symbol: TTPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steven R. Ph.D. Gullans: Director
Holdings: 1,468,505 shares
Current Value: $6,138,351
Latest Transaction: Mar 27 2013
$TTPH Market Capitalization: $155.73M
$TTPH Previous Close: $4.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Steven R. Ph.D. Gullans in TETRAPHASE PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, NRBO, TTPH

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Gullans Steven R. Ph.D.DirectorOption ExerciseA7.0720,000141,40020,000
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Gullans Steven R. Ph.D.DirectorOption ExerciseC0.0028,199,14400
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Gullans Steven R. Ph.D.DirectorBuyP7.00496,1213,472,8471,468,505972.4 K to 1.5 M (+51.02 %)
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Gullans Steven R. Ph.D.DirectorBuyC0.00972,3840972,3840 to 972.4 K

Page:   1